vs
Side-by-side financial comparison of Evolus, Inc. (EOLS) and IMAX CORP (IMAX). Click either name above to swap in a different company.
IMAX CORP is the larger business by last-quarter revenue ($125.2M vs $90.3M, roughly 1.4× Evolus, Inc.). IMAX CORP runs the higher net margin — 0.5% vs 0.1%, a 0.4% gap on every dollar of revenue. On growth, IMAX CORP posted the faster year-over-year revenue change (35.1% vs 14.4%). IMAX CORP produced more free cash flow last quarter ($28.0M vs $11.3M). Over the past eight quarters, IMAX CORP's revenue compounded faster (25.8% CAGR vs 23.4%).
Evolus, Inc. is a medical aesthetics company focused on developing and commercializing non-surgical cosmetic treatment solutions. Its flagship product is a prescription neuromodulator designed to reduce moderate to severe glabellar frown lines, serving licensed aesthetic healthcare providers and consumers across North America, Europe, and key Asia-Pacific regional markets.
IMAX Corporation is a Canadian production theatre company which designs and manufactures IMAX cameras and projection systems as well as performing film development, production, post-production and distribution to IMAX-affiliated theatres worldwide. Founded in Montreal in 1967, it has headquarters in the Toronto area, and operations in New York City and Los Angeles.
EOLS vs IMAX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $90.3M | $125.2M |
| Net Profit | $130.0K | $637.0K |
| Gross Margin | 65.7% | 57.6% |
| Operating Margin | 4.7% | 19.3% |
| Net Margin | 0.1% | 0.5% |
| Revenue YoY | 14.4% | 35.1% |
| Net Profit YoY | 101.9% | -88.0% |
| EPS (diluted) | $0.01 | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $90.3M | $125.2M | ||
| Q3 25 | $69.0M | $106.7M | ||
| Q2 25 | $69.4M | $91.7M | ||
| Q1 25 | $68.5M | $86.7M | ||
| Q4 24 | $78.9M | $92.7M | ||
| Q3 24 | $61.1M | $91.5M | ||
| Q2 24 | $66.9M | $89.0M | ||
| Q1 24 | $59.3M | $79.1M |
| Q4 25 | $130.0K | $637.0K | ||
| Q3 25 | $-15.7M | $20.7M | ||
| Q2 25 | $-17.1M | $11.3M | ||
| Q1 25 | $-18.9M | $2.3M | ||
| Q4 24 | $-6.8M | $5.3M | ||
| Q3 24 | $-19.2M | $13.9M | ||
| Q2 24 | $-11.3M | $3.6M | ||
| Q1 24 | $-13.1M | $3.3M |
| Q4 25 | 65.7% | 57.6% | ||
| Q3 25 | 66.5% | 63.1% | ||
| Q2 25 | 65.3% | 58.5% | ||
| Q1 25 | 68.1% | 61.4% | ||
| Q4 24 | 66.7% | 52.2% | ||
| Q3 24 | 68.9% | 55.8% | ||
| Q2 24 | 70.3% | 49.4% | ||
| Q1 24 | 68.3% | 59.3% |
| Q4 25 | 4.7% | 19.3% | ||
| Q3 25 | -16.7% | 27.2% | ||
| Q2 25 | -14.7% | 15.6% | ||
| Q1 25 | -22.1% | 19.3% | ||
| Q4 24 | -2.9% | 10.3% | ||
| Q3 24 | -25.3% | 21.2% | ||
| Q2 24 | -11.5% | 3.2% | ||
| Q1 24 | -15.0% | 15.3% |
| Q4 25 | 0.1% | 0.5% | ||
| Q3 25 | -22.8% | 19.4% | ||
| Q2 25 | -24.7% | 12.3% | ||
| Q1 25 | -27.6% | 2.7% | ||
| Q4 24 | -8.6% | 5.7% | ||
| Q3 24 | -31.4% | 15.2% | ||
| Q2 24 | -17.0% | 4.0% | ||
| Q1 24 | -22.1% | 4.1% |
| Q4 25 | $0.01 | $0.02 | ||
| Q3 25 | $-0.24 | $0.37 | ||
| Q2 25 | $-0.27 | $0.20 | ||
| Q1 25 | $-0.30 | $0.04 | ||
| Q4 24 | $-0.11 | $0.09 | ||
| Q3 24 | $-0.30 | $0.26 | ||
| Q2 24 | $-0.18 | $0.07 | ||
| Q1 24 | $-0.22 | $0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $53.8M | $151.2M |
| Total DebtLower is stronger | $146.1M | — |
| Stockholders' EquityBook value | $-23.1M | $337.9M |
| Total Assets | $225.9M | $894.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $53.8M | $151.2M | ||
| Q3 25 | $43.5M | $143.1M | ||
| Q2 25 | $61.7M | $109.3M | ||
| Q1 25 | $67.9M | $97.1M | ||
| Q4 24 | $87.0M | $100.6M | ||
| Q3 24 | $85.0M | $104.5M | ||
| Q2 24 | $93.7M | $91.6M | ||
| Q1 24 | $97.0M | $81.0M |
| Q4 25 | $146.1M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $121.8M | — | ||
| Q4 24 | $121.5M | — | ||
| Q3 24 | $121.2M | — | ||
| Q2 24 | $120.9M | — | ||
| Q1 24 | $120.6M | — |
| Q4 25 | $-23.1M | $337.9M | ||
| Q3 25 | $-28.8M | $349.5M | ||
| Q2 25 | $-18.7M | $320.4M | ||
| Q1 25 | $-6.6M | $299.5M | ||
| Q4 24 | $5.5M | $299.5M | ||
| Q3 24 | $5.9M | $289.4M | ||
| Q2 24 | $19.3M | $267.2M | ||
| Q1 24 | $18.4M | $258.8M |
| Q4 25 | $225.9M | $894.0M | ||
| Q3 25 | $219.0M | $889.6M | ||
| Q2 25 | $228.8M | $868.6M | ||
| Q1 25 | $213.4M | $848.3M | ||
| Q4 24 | $232.6M | $830.4M | ||
| Q3 24 | $229.6M | $847.6M | ||
| Q2 24 | $233.8M | $827.4M | ||
| Q1 24 | $226.2M | $824.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 22.00× | — | ||
| Q3 24 | 20.58× | — | ||
| Q2 24 | 6.26× | — | ||
| Q1 24 | 6.54× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $12.8M | $29.4M |
| Free Cash FlowOCF − Capex | $11.3M | $28.0M |
| FCF MarginFCF / Revenue | 12.6% | 22.3% |
| Capex IntensityCapex / Revenue | 1.6% | 1.1% |
| Cash ConversionOCF / Net Profit | 98.67× | 46.11× |
| TTM Free Cash FlowTrailing 4 quarters | $-45.7M | $118.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $12.8M | $29.4M | ||
| Q3 25 | $-14.7M | $67.5M | ||
| Q2 25 | $-24.8M | $23.2M | ||
| Q1 25 | $-15.6M | $7.0M | ||
| Q4 24 | $4.8M | $11.5M | ||
| Q3 24 | $-5.7M | $35.3M | ||
| Q2 24 | $-6.5M | $35.0M | ||
| Q1 24 | $-10.6M | $-11.0M |
| Q4 25 | $11.3M | $28.0M | ||
| Q3 25 | $-15.6M | $64.8M | ||
| Q2 25 | $-25.5M | $20.9M | ||
| Q1 25 | $-16.0M | $5.3M | ||
| Q4 24 | $4.4M | $6.9M | ||
| Q3 24 | $-6.0M | $34.2M | ||
| Q2 24 | $-6.9M | $33.5M | ||
| Q1 24 | $-10.9M | $-12.1M |
| Q4 25 | 12.6% | 22.3% | ||
| Q3 25 | -22.7% | 60.7% | ||
| Q2 25 | -36.7% | 22.8% | ||
| Q1 25 | -23.3% | 6.1% | ||
| Q4 24 | 5.5% | 7.4% | ||
| Q3 24 | -9.9% | 37.3% | ||
| Q2 24 | -10.4% | 37.6% | ||
| Q1 24 | -18.3% | -15.3% |
| Q4 25 | 1.6% | 1.1% | ||
| Q3 25 | 1.4% | 2.6% | ||
| Q2 25 | 1.0% | 2.6% | ||
| Q1 25 | 0.5% | 1.9% | ||
| Q4 24 | 0.6% | 5.0% | ||
| Q3 24 | 0.5% | 1.2% | ||
| Q2 24 | 0.7% | 1.8% | ||
| Q1 24 | 0.4% | 1.4% |
| Q4 25 | 98.67× | 46.11× | ||
| Q3 25 | — | 3.27× | ||
| Q2 25 | — | 2.06× | ||
| Q1 25 | — | 2.99× | ||
| Q4 24 | — | 2.16× | ||
| Q3 24 | — | 2.54× | ||
| Q2 24 | — | 9.78× | ||
| Q1 24 | — | -3.35× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EOLS
Segment breakdown not available.
IMAX
| Technology Sales | $46.6M | 37% |
| Image Enhancement And Maintenance Services | $38.1M | 30% |
| Joint Revenue Sharing Arrangement | $20.4M | 16% |
| Maintenance | $16.3M | 13% |
| Finance Income | $2.8M | 2% |
| Other Content Solutions | $1.6M | 1% |
